Mini-Pe (Norethisterone)

Norethisterone, the active ingredient in Mini-Pe, is a Progestogen (Progestin) presented as an oral dosage form for systemic use. It is used to prevent pregnancy and to treat various menstrual disorders in women of reproductive age.

GNH USA supplies Mini-Pe as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Norethisterone acts on the hormonal pathways that regulate the menstrual cycle and ovulation, providing both contraceptive and therapeutic effects. - Contraception: prevents pregnancy by suppressing ovulation and altering cervical mucus. - Menstrual disorders: reduces irregular bleeding and dysmenorrhea, helping to regularise cycles. - Endometriosis: alleviates pain and lesion progression by stabilising hormonal fluctuations. - Premenstrual syndrome (PMS): lessens mood swings, breast tenderness and other pre‑menstrual symptoms.

Norethisterone may cause a range of adverse reactions, from mild to severe. Patients should be aware of both common and rare events.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Breast tenderness: discomfort or swelling of breast tissue. - Headache: occasional tension‑type headaches. - Irregular bleeding: spotting or breakthrough bleeding. - Mood changes: mild irritability or emotional fluctuations. - Weight gain: modest increase in body weight.

Serious or Rare Side Effects: - Thromboembolic events: deep‑vein thrombosis or pulmonary embolism. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Hepatic dysfunction: jaundice or abnormal liver enzymes. - Depression: new or worsening depressive symptoms. - Visual disturbances: blurred vision or ocular pain. - Persistent abdominal pain: may indicate serious intra‑abdominal pathology.

Before prescribing Mini-Pe, clinicians should evaluate patient history and risk factors. - Pregnancy contraindication: product is Category X and must not be used during pregnancy. - Breastfeeding: avoid unless benefits outweigh potential risks to the infant. - History of thromboembolism: contraindicated due to increased clotting risk. - Liver disease: use with caution; monitor hepatic function. - Drug interactions: review concomitant medications for potential interactions. - Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Norethisterone can interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid): - Combined hormonal contraceptives: additive progestogenic effect may increase side‑effects. - Antifungal azoles (e.g., ketoconazole): may raise plasma norethisterone levels. - Antiepileptic enzyme inducers (e.g., carbamazepine): can reduce contraceptive effectiveness. - Strong CYP3A4 inhibitors (e.g., ritonavir): may increase drug exposure.

Moderate Interactions (Monitor Closely): - Rifampicin and other potent inducers: may diminish efficacy, requiring alternative contraception. - St. John’s wort: herbal inducer that can lower drug concentrations. - Certain antibiotics (e.g., metronidazole): may modestly affect hormone levels.